19-12649904-ACC-ACCC
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_000528.4(MAN2B1):c.2267+8_2267+9insG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00805 in 1,535,290 control chromosomes in the GnomAD database, including 61 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0052 ( 3 hom., cov: 28)
Exomes 𝑓: 0.0083 ( 58 hom. )
Consequence
MAN2B1
NM_000528.4 intron
NM_000528.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.840
Genes affected
MAN2B1 (HGNC:6826): (mannosidase alpha class 2B member 1) This gene encodes an enzyme that hydrolyzes terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. Its activity is necessary for the catabolism of N-linked carbohydrates released during glycoprotein turnover and it is member of family 38 of glycosyl hydrolases. The full length protein is processed in two steps. First, a 49 aa leader sequence is cleaved off and the remainder of the protein is processed into 3 peptides of 70 kDa, 42 kDa (D) and 13/15 kDa (E). Next, the 70 kDa peptide is further processed into three peptides (A, B and C). The A, B and C peptides are disulfide-linked. Defects in this gene have been associated with lysosomal alpha-mannosidosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 19-12649904-A-AC is Benign according to our data. Variant chr19-12649904-A-AC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 290029.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00524 (702/133926) while in subpopulation NFE AF= 0.00917 (569/62074). AF 95% confidence interval is 0.00854. There are 3 homozygotes in gnomad4. There are 303 alleles in male gnomad4 subpopulation. Median coverage is 28. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAN2B1 | NM_000528.4 | c.2267+8_2267+9insG | intron_variant | ENST00000456935.7 | |||
MAN2B1 | NM_001173498.2 | c.2264+8_2264+9insG | intron_variant | ||||
MAN2B1 | XM_005259913.3 | c.2270+8_2270+9insG | intron_variant | ||||
MAN2B1 | XM_047438841.1 | c.1166+8_1166+9insG | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAN2B1 | ENST00000456935.7 | c.2267+8_2267+9insG | intron_variant | 1 | NM_000528.4 | A1 | |||
MAN2B1 | ENST00000221363.8 | c.2264+8_2264+9insG | intron_variant | 1 | P4 | ||||
MAN2B1 | ENST00000466794.5 | n.2857+8_2857+9insG | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00524 AC: 702AN: 133860Hom.: 3 Cov.: 28
GnomAD3 genomes
AF:
AC:
702
AN:
133860
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00414 AC: 1040AN: 251360Hom.: 6 AF XY: 0.00423 AC XY: 575AN XY: 135838
GnomAD3 exomes
AF:
AC:
1040
AN:
251360
Hom.:
AF XY:
AC XY:
575
AN XY:
135838
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00832 AC: 11658AN: 1401364Hom.: 58 Cov.: 33 AF XY: 0.00790 AC XY: 5520AN XY: 698422
GnomAD4 exome
AF:
AC:
11658
AN:
1401364
Hom.:
Cov.:
33
AF XY:
AC XY:
5520
AN XY:
698422
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00524 AC: 702AN: 133926Hom.: 3 Cov.: 28 AF XY: 0.00467 AC XY: 303AN XY: 64872
GnomAD4 genome
AF:
AC:
702
AN:
133926
Hom.:
Cov.:
28
AF XY:
AC XY:
303
AN XY:
64872
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Deficiency of alpha-mannosidase Uncertain:1Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 11, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | MAN2B1: BS2 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 12, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at